News of Note—Neurostimulation player ElectroCore bags $36M; Ethicon slammed with $57M pelvic mesh verdict

News of note

> ElectroCore, which markets a noninvasive vagus nerve stimulation device that treats pain associated with episodic cluster headaches, raised $36 million. SEC filing

> Johnson & Johnson’s Ethicon unit was ordered to pay $57.1 million in a pelvic mesh suit. Philadelphia Inquirer article

> The FDA cleared MyndTec’s functional electric stimulation system for the treatment of patients with upper extremity paralysis. Release

The MedTech Conference

The MedTech Conference: September 23-25, Boston, MA

With over 3,000 attendees from 35 countries, The MedTech Conference features world-class plenary speakers, cross-cutting educational programming and business development opportunities. This is a prime opportunity to network, conduct business and share insights with medtech leaders. Register before July 26th and save $200!

Suggested Articles

Eisai showed correlations between amyloid biomarkers in the blood and cerebrospinal fluid, bringing it closer to a simple blood test for Alzheimer’s.

Elon Musk pulled back the curtain on his brain interface-developing Neuralink, saying the startup holds the promise of merging people with AI.

The partners will study patient-focused endpoints alongside so-called “hard outcomes" that have traditionally served as endpoints in clinical trials.